14 years treating AML
Dr. Abel's research aims to apply health services methods to understand the experiences of patients with cancer and to answer questions about the effectiveness of cancer care. He is also interested in evaluating how intensive cancer therapy affects outcomes other than survival, such as quality of life and financial well-being. He primarily focuses on the hematologic malignancies, studying the impact of these diseases and their treatment from diagnosis to the end of life.
Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.
Terms of Use and Privacy Policy Newsroom About Donations Find an AML Specialist Newsletter Learn Connect
Copyright © 2022 HealthTree Foundation. All Rights Reserved.
The HealthTree Foundation / HealthTree for AML is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811